A Study of Venetoclax Plus Lenalidomide and Dexamethasone for the Treatment of Newly Diagnosed t(11;14)-Positive Multiple Myeloma in Subjects Who Are Ineligible for High-Dose Therapy
Clinical trial NCT03785184 · WITHDRAWN
Trial details
- NCT number
- NCT03785184
- Sponsor
- AbbVie
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-29
- Primary completion
- 2019-08-22
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.